Expert review of neurotherapeutics - Drugs and Drug Development

Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's.

Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:

Expert Commentary - a personal view on the most effective or promising strategies
Five-year view - a clear perspective of future prospects within a realistic time scale
Key issues - an executive summary cutting to the author's most critical points

Issue themes are:

* Schizophrenia; Mood disorders (January/July)
* Stroke; Anxiety disorders (February/August)
* Migraine and headache; Demyelinating diseases (March/September)
* CNS neoplasms; Attention deficit and hyperactivity (April/October)
* Alzheimer's disease; Pain (May/November)
* Parkinson's disease; Epilepsy (June/December)

Indexing

* MEDLINE/Index Medicus
* EMBASE/Excerpta Medica
* Chemical Abstracts
* Scopus

Title Abbreviation:
Expert Rev Neurother
Title(s):
Expert review of neurotherapeutics.
Publication Date(s):
Vol. 1, no. 1 (Sept. 2001)-
Frequency:
Bimonthly 2002-
Publisher:
London : Future Drugs Ltd., 2001-
Description:
v.
Language:
English
ISSN:
1473-7175 (Print)
1744-8360 (Electronic)